INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 140 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2017. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $389,000 | -21.9% | 8,357 | -4.1% | 0.15% | -39.4% |
| Q2 2022 | $498,000 | +78.5% | 8,716 | -19.9% | 0.25% | -64.4% |
| Q3 2020 | $279,000 | +27.4% | 10,882 | +7.6% | 0.70% | +636.8% |
| Q3 2018 | $219,000 | -58.9% | 10,109 | -66.5% | 0.10% | -43.8% |
| Q2 2018 | $533,000 | +38.1% | 30,162 | +13.3% | 0.17% | +49.6% |
| Q4 2017 | $386,000 | -1.0% | 26,625 | +7.8% | 0.11% | +2.7% |
| Q3 2017 | $390,000 | +68.8% | 24,700 | +61.4% | 0.11% | -9.1% |
| Q4 2016 | $231,000 | -27.4% | 15,300 | +86.6% | 0.12% | -21.4% |
| Q2 2016 | $318,000 | – | 8,200 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |